Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.

Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, Lippe B.

J Clin Endocrinol Metab. 2005 Sep;90(9):5247-53. Epub 2005 Jul 5.

PMID:
15998780
[PubMed - indexed for MEDLINE]
2.

Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.

Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O, Aman J.

J Clin Endocrinol Metab. 2008 Nov;93(11):4342-50. doi: 10.1210/jc.2008-0707. Epub 2008 Aug 26.

PMID:
18728172
[PubMed - indexed for MEDLINE]
3.
4.

Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.

Pasquino AM, Pucarelli I, Roggini M, Segni M.

J Clin Endocrinol Metab. 2000 Feb;85(2):619-22.

PMID:
10690865
[PubMed - indexed for MEDLINE]
5.

High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.

Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.

J Clin Endocrinol Metab. 2000 Oct;85(10):3653-60.

PMID:
11061518
[PubMed - indexed for MEDLINE]
6.

A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.

Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.

J Clin Endocrinol Metab. 2001 Jul;86(7):2969-75.

PMID:
11443153
[PubMed - indexed for MEDLINE]
7.

Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.

Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS; Australasian Paediatric Endocrine Group (APEG).

Clin Endocrinol (Oxf). 2012 Jul;77(1):62-71. doi: 10.1111/j.1365-2265.2011.04230.x.

PMID:
21950731
[PubMed - indexed for MEDLINE]
8.

Safety of growth hormone treatment in pediatric patients with idiopathic short stature.

Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB Jr.

J Clin Endocrinol Metab. 2005 Sep;90(9):5188-96. Epub 2005 May 17.

PMID:
15899952
[PubMed - indexed for MEDLINE]
9.

Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.

Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO; KIGS International Board.

Horm Res. 2007;68(2):53-62. Epub 2007 Jan 16.

PMID:
17228181
[PubMed - indexed for MEDLINE]
10.

Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.

de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.

J Clin Endocrinol Metab. 1999 May;84(5):1558-61.

PMID:
10323379
[PubMed - indexed for MEDLINE]
11.

Lessons from the national cooperative growth study.

Wyatt D.

Eur J Endocrinol. 2004 Aug;151 Suppl 1:S55-9.

PMID:
15339245
[PubMed - indexed for MEDLINE]
Free Article
12.

Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.

Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.

J Clin Endocrinol Metab. 2009 Feb;94(2):483-90. doi: 10.1210/jc.2008-1503. Epub 2008 Nov 11.

PMID:
19001519
[PubMed - indexed for MEDLINE]
13.

Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.

Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, Lippe B.

J Clin Endocrinol Metab. 2009 Jul;94(7):2338-44. doi: 10.1210/jc.2008-2094. Epub 2009 Apr 28.

PMID:
19401366
[PubMed - indexed for MEDLINE]
14.

Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.

Fjellestad-Paulsen A, Simon D, Czernichow P.

J Clin Endocrinol Metab. 2004 Mar;89(3):1234-9.

PMID:
15001616
[PubMed - indexed for MEDLINE]
15.

Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.

Root AW, Kemp SF, Rundle AC, Dana K, Attie KM.

J Pediatr Endocrinol Metab. 1998;11(3):403-12.

PMID:
11517956
[PubMed - indexed for MEDLINE]
16.

Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.

Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L.

Arch Pediatr Adolesc Med. 2002 Mar;156(3):230-40.

PMID:
11876666
[PubMed - indexed for MEDLINE]
17.

The effect of growth hormone treatment on height in children with idiopathic short stature.

Jeong HR, Shim YS, Lee HS, Hwang JS.

J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):629-33. doi: 10.1515/jpem-2013-0461.

PMID:
24810558
[PubMed - indexed for MEDLINE]
18.

Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.

Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group.

J Clin Endocrinol Metab. 2010 May;95(5):2089-98. doi: 10.1210/jc.2009-2139. Epub 2010 Mar 5.

PMID:
20207829
[PubMed - indexed for MEDLINE]
19.

Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial.

Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler GB Jr, Baron J; National Institute of Child Health and Human Development-Eli Lilly & Co. Growth Hormone Collaborative Group.

J Clin Endocrinol Metab. 2004 Jul;89(7):3140-8.

PMID:
15240584
[PubMed - indexed for MEDLINE]
20.

Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.

Sävendahl L, Maes M, Albertsson-Wikland K, Borgström B, Carel JC, Henrard S, Speybroeck N, Thomas M, Zandwijken G, Hokken-Koelega A.

J Clin Endocrinol Metab. 2012 Feb;97(2):E213-7. doi: 10.1210/jc.2011-2882. Epub 2012 Jan 11.

PMID:
22238393
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk